Ard.bmj.com

Ard Bmj. A leading rheumatology journal published by BMJ and EULAR.

Today's Ard.bmj.com headlines: Observe fresh posts and updates on Ard Bmj. It has already delivered 10+ fresh articles to 110K users this month. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Ard Bmj

Subscribe to related news

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting
via sdbn

Data presentations include:- Positive results from Period 1 of the C-EARLY(TM) Phase 3 study of CIMZIA® (certolizumab pegol) combined with optimized methotrexate treatment in DMARD-naive, recently diagnosed, adult rheumatoid arthritis patients with moderate...
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for ...
via bmjopen.bmj

Introduction Cardiovascular morbidity is a major burden in patients with rheumatoid arthritis (RA). In this study, we compare the effect of a targeted, intensified, multifactorial intervention with that of conventional treatment of modifiable risk factors...
New long-term data on Cimzia® (certolizumab pegol) presented at EULAR 2014 shows sustained outcomes in patients with spo...
via totalbiopharma

June 12 2014: New long-term data on Cimzia® (certolizumab pegol) presented at EULAR 2014 shows sustained outcomes in patients with spondyloarthritis. New 96-week interim data cut from the RAPIDTM-PsA and -axSpA studies showed that improvements in disease...
The Holistic Prevention, Management and Treatment of Rheumatoid Arthritis back by Research and Studies of Renowned Insti...
via kylejnorton.blogspot

Kyle J. Norton (Scholar) Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news...
The social (media) side to rheumatology : Nature Reviews Rheumatology
via hcsm.plus91

Abstract A revolution is underway in the fields of education and health practice. Social media are now considered by the new generations of students, doctors and patients as a useful tool for learning and for doctor–doctor, doctor–patient...

Ard.bmj.com popular pages

Homepage | Annals of the Rheumatic Diseases

The homepage of Annals of the Rheumatic Diseases, a leading rheumatology journal published by BMJ and EULAR.
AB0937 Prevalence of psoriatic arthritis in psoriasis patients according to new classification criteria | Annals of the Rheumatic

Background Several classification criteria for Psoriatic Arthritis (PsA) have been proposed, being CASPAR criteria the most accepted at present. Recently ASAS has proposed classification criteria for ...

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Background Baricitinib is an oral, reversible, selective Janus kinase 1 and 2 inhibitor. Methods In this phase III, double-blind 24-week study, 684 biologic disease-modifying antirheumatic drug (DMAR...
Preliminary classification criteria for the cryoglobulinaemic vasculitis | Annals of the Rheumatic Diseases

Background To develop preliminary classification criteria for the cryoglobulinaemic syndrome or cryoglobulinaemic vasculitis (CV). Methods Study part I developed a questionnaire for CV to be included...